Associations of Polymorphisms in HPC2/ELAC2 and SRD5A2 Genes with Benign Prostate Hyperplasia in Turkish Men

被引:0
作者
Izmirli, Muzeyyen [1 ]
Arikan, Burhan [2 ]
Bayazit, Yildirim [3 ]
Alptekin, Davut [4 ]
机构
[1] Bezmialem Vakif Univ, Fac Med, Dept Med Biol, Istanbul, Turkey
[2] Cukurova Univ, Fac Sci, Dept Mol Biol, Adana, Turkey
[3] Cukurova Univ, Fac Med, Dept Urol, Adana, Turkey
[4] Cukurova Univ, Fac Med, Dept Med Biol, Adana, Turkey
关键词
HPC2/ELAC2; gene; SRD5A2; polymorphism; BPH; Turkey; CANCER RISK;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Benign prostate hyperplasia (BPH) is the most common benign tumor in elderly men for which the HPC2/ELAC2 and SRD5A2 genes are known genetic factors. The HPC2/ELAC2 gene features Ser217Leu and Ala541Thr polymorphisms and the SRD5A2 gene Ala49Thr and Val89Leu polymorphisms. The aim of this study was to examine relationships between these polymorphisms and BPH in Turkish men using amplification by the polymerase chain reaction (PCR) method. Polymorphisms were determined by using restriction fragment length polymorphism (RFLP) with suitable restriction: TaqI alpha, Fnu4HI, Mwo I and Rsa I. We found statistically significant relationship between the SRD5A2 gene Ala49Thr (OR=2.3; CI 95%, 1.04-5.1; p=0.01<0.05), but not the other polymorphisms, and BPH. For the first time, our data demonstrate that correlation between SRD5A2 gene Ala49Thr and polymorphism are statistically significant in Turkish men with BPH.
引用
收藏
页码:731 / 733
页数:3
相关论文
共 15 条
[1]   Impact of constitutional genetic variation in androgen/oestrogen-regulating genes on age-related changes in human prostate [J].
Azzouzi, AR ;
Cochand-Priollet, B ;
Mangin, P ;
Fournier, G ;
Berthon, P ;
Latil, A ;
Cussenot, O .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (04) :479-484
[2]   Association of prostate cancer risk and aggressiveness to androgen pathway genes:: SRD5A2, CYP17, and the AR [J].
Cicek, MS ;
Conti, DV ;
Curran, A ;
Neville, PJ ;
Paris, PL ;
Casey, G ;
Witte, JS .
PROSTATE, 2004, 59 (01) :69-76
[3]  
Jaffe JM, 2000, CANCER RES, V60, P1626
[4]   A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH [J].
Klotsman, M ;
Weinberg, CR ;
Davis, K ;
Binnie, CG ;
Hartmann, KE .
PHARMACOGENOMICS JOURNAL, 2004, 4 (04) :251-259
[5]   STRUCTURE OF HUMAN TYPE-II 5-ALPHA-REDUCTASE GENE [J].
LABRIE, F ;
SUGIMOTO, Y ;
LUUTHE, V ;
SIMARD, J ;
LACHANCE, Y ;
BACHVAROV, D ;
LEBLANC, G ;
DUROCHER, F ;
PAQUET, N .
ENDOCRINOLOGY, 1992, 131 (03) :1571-1573
[6]   Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population [J].
Li, ZH ;
Habuchi, T ;
Mitsumori, K ;
Kamoto, T ;
Kinoshitu, H ;
Segawa, T ;
Ogawa, O ;
Kato, T .
JOURNAL OF UROLOGY, 2003, 169 (06) :2378-2381
[7]  
Makridakis N, 1997, CANCER RES, V57, P1020
[8]   Molecular epidemiology of hormone-metabolic loci in prostate cancer [J].
Makridakis, NM ;
Reichardt, JKV .
EPIDEMIOLOGIC REVIEWS, 2001, 23 (01) :24-29
[9]   Longer (TA)n Repeat but Not A49T and V89L Polymorphisms in SRD5A2 Gene May Confer Prostate Cancer Risk in South Indian Men [J].
Rajender, Singh ;
Vijayalakshmi, Krishnaswamy ;
Pooja, Singh ;
Madhavi, Sakhamuri ;
Paul, Solomon F. D. ;
Vettriselvi, V. ;
Shroff, Sunil ;
Singh, Lalji ;
Thangaraj, Kumarasamy .
JOURNAL OF ANDROLOGY, 2009, 30 (06) :703-710
[10]   Association of HPC2/ELAC2 genotypes and prostate cancer [J].
Rebbeck, TR ;
Walker, AH ;
Zeigler-Johnson, C ;
Weisburg, S ;
Martin, AM ;
Nathanson, KL ;
Wein, AJ ;
Malkowicz, SB .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 67 (04) :1014-1019